AP2001002093A0 - Dry powder active agent pulmonary delivery - Google Patents

Dry powder active agent pulmonary delivery

Info

Publication number
AP2001002093A0
AP2001002093A0 AP2001002093A AP2001002093A AP2001002093A0 AP 2001002093 A0 AP2001002093 A0 AP 2001002093A0 AP 2001002093 A AP2001002093 A AP 2001002093A AP 2001002093 A AP2001002093 A AP 2001002093A AP 2001002093 A0 AP2001002093 A0 AP 2001002093A0
Authority
AP
ARIPO
Prior art keywords
active agent
dry powder
pulmonary delivery
powder active
agent pulmonary
Prior art date
Application number
AP2001002093A
Other versions
AP1374A (en
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of AP2001002093A0 publication Critical patent/AP2001002093A0/en
Application granted granted Critical
Publication of AP1374A publication Critical patent/AP1374A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
APAP/P/2001/002093A 1998-09-14 1999-09-13 Aerosolizable particles resistant to hygroscopic growth. AP1374A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (2)

Publication Number Publication Date
AP2001002093A0 true AP2001002093A0 (en) 2001-03-31
AP1374A AP1374A (en) 2005-02-28

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002093A AP1374A (en) 1998-09-14 1999-09-13 Aerosolizable particles resistant to hygroscopic growth.

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198593C (en) 1999-06-09 2005-04-27 罗伯特·E·希弗斯 Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
BR0307935A (en) 2002-02-25 2005-03-29 Diffusion Pharmaceuticals Llc Bipolar Trans Carotenoid Salts And Their Uses
JP2006513139A (en) * 2002-07-03 2006-04-20 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド Central airway administration for systemic delivery of therapeutic agents
ES2280835T3 (en) * 2002-12-19 2007-09-16 Pharmacia Corporation NON-HYGROSCOPIC FORMULATION THAT INCLUDES A HYGROSCOPIC PHARMACO.
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CA2562585A1 (en) * 2004-04-23 2005-11-10 Cydex, Inc. Dpi formulation containing sulfoalkyl ether cyclodextrin
CA2598882C (en) * 2005-02-24 2020-02-25 Diffusion Pharmaceuticals Llc Trans carotenoids, their synthesis, formulation and uses
AU2006221364A1 (en) * 2005-03-09 2006-09-14 Ono Pharmaceutical Co., Ltd. Particle and preparation containing the particle
SI2335707T1 (en) 2005-10-26 2015-09-30 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
WO2008050847A1 (en) * 2006-10-25 2008-05-02 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
JP2010524855A (en) 2007-04-13 2010-07-22 ディフュージョン・ファーマシューティカルズ・エルエルシー Use of bipolar trans carotenoids as and in the pretreatment of peripheral vascular disease
CN101878040A (en) 2007-10-31 2010-11-03 扩散药品有限公司 A new class of therapeutics that enhance small molecule diffusion
ES2661215T3 (en) 2009-05-20 2018-03-28 Aeras Viral compositions; immunogens; spray dried; stable
AU2010263245A1 (en) 2009-06-22 2012-01-19 Diffusion Pharmaceuticals Llc Diffusion enhancing compounds and their use alone or with thrombolytics
KR101891357B1 (en) 2010-06-02 2018-08-24 디퓨젼 파마슈티컬즈 엘엘씨 Oral formulations of bipolar trans carotenoids
SG10201607288VA (en) 2012-05-03 2016-10-28 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (en) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
WO2015042352A1 (en) * 2013-09-20 2015-03-26 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
DK3212212T3 (en) 2014-10-31 2020-12-21 Univ Monash POWDER FORMULATION
KR20230014850A (en) 2016-03-24 2023-01-30 디퓨젼 파마슈티컬즈 엘엘씨 Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
ES2177544T3 (en) * 1992-06-12 2002-12-16 Teijin Ltd ULTRAFININE POWDER TO INHALATE AND METHOD FOR PREPARATION.
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
DE69732306T2 (en) * 1997-01-16 2006-01-12 Massachusetts Institute Of Technology, Cambridge PREPARATION OF PARTICLE MEDICINES FOR INHALATION
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
GT199900156A (en) 2001-03-07
CN1317977A (en) 2001-10-17
BG105430A (en) 2001-12-29
DZ2892A1 (en) 2003-12-15
SA99200718B1 (en) 2006-11-04
IS5878A (en) 2001-03-05
GEP20043257B (en) 2004-06-25
HUP0103837A3 (en) 2002-11-28
LT4897B (en) 2002-02-25
BR9913722A (en) 2001-05-29
TWI226248B (en) 2005-01-11
UY25711A1 (en) 1999-11-17
JP2002524535A (en) 2002-08-06
OA11781A (en) 2005-07-26
LV12658B (en) 2001-09-20
IL141562A0 (en) 2002-03-10
HN1999000159A (en) 1999-11-11
AP1374A (en) 2005-02-28
AU753014B2 (en) 2002-10-03
EP1117442A1 (en) 2001-07-25
EA003476B1 (en) 2003-06-26
HUP0103837A2 (en) 2002-05-29
KR20010075063A (en) 2001-08-09
MY129282A (en) 2007-03-30
EA200100300A1 (en) 2001-10-22
TR200101182T2 (en) 2001-09-21
CZ2001829A3 (en) 2001-09-12
PA8481901A1 (en) 2002-04-25
IL141562A (en) 2007-07-24
LV12658A (en) 2001-05-20
PL195574B1 (en) 2007-10-31
AR022090A1 (en) 2002-09-04
PE20001061A1 (en) 2000-10-08
CO5130023A1 (en) 2002-02-27
AU6039799A (en) 2000-04-03
HK1042231A1 (en) 2002-08-09
ID28845A (en) 2001-07-05
NO20011251L (en) 2001-04-17
YU24201A (en) 2003-08-29
NZ510168A (en) 2003-09-26
EE200100151A (en) 2002-06-17
HRP20010189A2 (en) 2005-04-30
MA25590A1 (en) 2002-12-31
CA2343920A1 (en) 2000-03-23
LT2001021A (en) 2001-11-26
SK3442001A3 (en) 2001-11-06
ZA200101995B (en) 2002-03-11
WO2000015262A1 (en) 2000-03-23
TNSN99173A1 (en) 2005-11-10
NO20011251D0 (en) 2001-03-13
UA76085C2 (en) 2006-07-17
PL346768A1 (en) 2002-02-25

Similar Documents

Publication Publication Date Title
AP2001002093A0 (en) Dry powder active agent pulmonary delivery
EP0927025A4 (en) Liposome encapsulated active agent dry powder composition
HUP0001799A3 (en) Dry powder inhaler
PL343276A1 (en) Aerosolized active agent delivery
EP1307256A4 (en) Dry powder inhaler
SI1294421T1 (en) Dry Powder Inhaler
HUP9903819A3 (en) Dry powder inhaler
AU9043201A (en) Continuous dry powder inhaler
IL137472A0 (en) Microparticle inhalation formulations
HUP0203728A3 (en) Aerosol composition comprising formoterol
DE60035911D1 (en) dry powder inhaler
HUP0104483A3 (en) Fungicidal active substance combinations and use thereof
HU9602818D0 (en) Dry powder inhaler
HUP0104579A3 (en) Glp-1 analogues, pharmaceutical compositions comprising thereof and their use
EP1487417A4 (en) Dry powder medicament formulations
HK1064313A1 (en) Powder formulation disintegrating system and dry powder inhalers
PL341820A1 (en) Coating composition in the form of dry powder
IL147390A0 (en) Dry powder compositions
GB0003935D0 (en) Formulation for dry powder inhaler
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
GB9719093D0 (en) Improvements to dry powder inhalers
AU1752601A (en) Dry powder inhaler
CZ20021359A3 (en) Preparation for fighting dry rots
GB0028828D0 (en) Improved pesticide formulation
AU129749S (en) Dry powder inhaler